Observational studyPloS one2021

Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.

Takanori Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.